![Guy MacDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Guy MacDonald
Président chez
SCYNEXIS, INC.
Fortune : 12 130 $ au 31/05/2026
Profil
Mr. Guy MacDonald is a Chairman at SCYNEXIS, Inc. Mr. MacDonald was previously employed as an Executive Vice President-Operations by Idenix Pharmaceuticals LLC, a Vice President-Anti Infective & Hospital Products by Merck & Co., Inc., and a Chairman by Spring Bank Pharmaceuticals, Inc. He also served on the board at Tetraphase Pharmaceuticals, Inc. He received his undergraduate degree from the University Of Dundee.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SCYNEXIS, INC. 0,02% | 01/04/2026 | 17 206 ( 0,02% ) | 12 130 $ | 31/05/2026 |
Postes actifs de Guy MacDonald
| Sociétés | Poste | Début |
|---|---|---|
| SCYNEXIS, INC. | Président | 04/06/2015 |
Anciens postes connus de Guy MacDonald
| Sociétés | Poste | Fin |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Directeur Général | 01/08/2019 |
| SPRING BANK PHARMACEUTICALS, INC. | Président | 17/08/2015 |
| IDENIX PHARMACEUTICALS INC | Directeur des opérations | 01/01/2008 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2003 |
Formation de Guy MacDonald
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
